Leidos Holdings Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Leidos Holdings de 5.8% y 5.2% por año respectivamente. Se prevé que el BPA crezca en un 8.5% al año. Se espera que la rentabilidad financiera sea de 26.3% en 3 años.
Información clave
5.8%
Tasa de crecimiento de los beneficios
8.50%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Professional Services | 15.5% |
| Tasa de crecimiento de los ingresos | 5.2% |
| Rentabilidad financiera futura | 26.31% |
| Cobertura de analistas | Good |
| Última actualización | 03 Jun 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • May 27
LDOS: Federal IT Wins And Hypersonic Programs Will Support Re Rating
Leidos Holdings' analyst price target has been revised lower by roughly $13 to about $186, as analysts update their models for a higher discount rate, a lower future P/E, and refreshed views from recent target cuts and a neutral initiation alongside one target increase. Analyst Commentary Recent Street research on Leidos Holdings has centered on recalibrated price targets, with several reductions and one increase, along with a fresh neutral initiation.Seeking Alpha • May 26
Leidos: The Market Is Mispricing This Defense Giant, Again
Summary Leidos (LDOS) is rated Strong Buy as the market underappreciates its alignment with federal priorities and robust operational performance. LDOS raised full-year guidance across all metrics, reporting Q1 revenue and EPS beats, and a record $48.4B backlog, yet trades at 10.5x forward earnings. ENTRUST acquisition expands LDOS’s cybersecurity capabilities, is immediately accretive, and positions the company for multi-year digital modernization tailwinds. Current valuation is compelling given mid-teens EBITDA margins, disciplined capital allocation, and strategic contract wins in missile defense and hypersonic weapons. Read the full article on Seeking AlphaActualización de narrativa • May 02
LDOS: Defense Tech Contracts And AI Alliance Will Offset 2026 VBA Drag
The updated analyst price target for Leidos Holdings has been trimmed by about $5 to roughly $199 per share. Analysts factored in recent target cuts around mixed Q4 results, modestly lower revenue growth assumptions, a slightly higher discount rate, and a somewhat lower future P/E multiple, even as profit margin expectations edge up.Actualización de narrativa • Apr 17
LDOS: Defense Tech And AI Partnership Will Offset 2026 VBA Headwinds
Leidos Holdings' updated analyst price target has moved lower by about $5 per share to reflect a slightly higher discount rate, a reduced future P/E assumption, and tempered margin expectations, as analysts factor in mixed Q4 results, recent target cuts from several firms, and ongoing headwinds in Veterans Benefits Administration work, even as growth initiatives continue. Analyst Commentary Recent research updates on Leidos point to a more cautious valuation framework, even as some analysts still see upside tied to growth investments and capital allocation changes.Actualización de narrativa • Apr 03
LDOS: Defense Tech And AI Contracts Will Offset 2026 VBA Slowdown
Analysts have trimmed the average price target for Leidos Holdings to $209 from about $212, reflecting slightly higher discount rate assumptions, modestly adjusted growth and margin expectations, and mixed reactions to recent Q4 results and contract headwinds. Analyst Commentary Recent research paints a mixed picture around Leidos Holdings, with both optimistic and cautious views emerging after the latest Q4 report, updated guidance, and evolving contract exposure.Actualización de narrativa • Mar 19
LDOS: Defense Tech And AI Expansion Will Offset 2026 VBA Contract Slowdown
Analysts have trimmed the blended price target on Leidos Holdings by about $1.50 to roughly $212.50, reflecting slightly softer long term growth and margin assumptions after mixed Q4 results and evolving views on the VBA headwind and defense tech opportunities. Analyst Commentary Street research on Leidos Holdings has shifted toward a more balanced view, with price targets generally nudged lower and ratings clustered around Buy, Outperform, Hold, and Neutral.Actualización de narrativa • Mar 05
LDOS: Defense Tech And AI Shift Will Offset 2026 VBA Headwinds
Analysts have reduced their blended price target for Leidos Holdings by about $4 to roughly $214, reflecting recent Q4 updates, mixed views on growth in 2026, and ongoing debate around the impact of slower Veterans Benefits Administration work versus opportunities in defense tech and other growth segments. Analyst Commentary Street research on Leidos presents a split view, with several firms trimming price targets after Q4 while still highlighting long term growth opportunities in defense technology and other higher growth areas.Actualización de narrativa • Feb 18
LDOS: Defense Tech And AI Shift Will Support Premium Multiple
The updated fair value estimate for Leidos Holdings edges down to about $218 per share from roughly $219, as analysts adjust price targets lower, citing mixed Q4 results, a slowdown in Veterans Benefits Administration activity, and tempered views on future valuation and guidance, even as the company increases its focus on higher growth markets. Analyst Commentary Recent Street research on Leidos points to a split view, with some analysts focusing on long term growth opportunities and others stressing execution risks and valuation constraints following the latest Q4 report and guidance.Actualización de narrativa • Feb 04
LDOS: Entrust Acquisition And AI Partnerships Will Support Premium Multiple
Analysts nudged their blended price target on Leidos Holdings slightly higher to about US$219.31, reflecting a modestly higher assumed future P/E multiple while balancing recent target moves tied to enthusiasm around the Entrust acquisition and caution over potential 2026 contract headwinds. Analyst Commentary Recent research on Leidos highlights a split view, with some analysts leaning into the potential of the Entrust acquisition and others more focused on contract concentration and 2026 risk.Actualización de narrativa • Jan 21
LDOS: Health And Civil Strength And VA Contract Risk Will Shape Premium Multiple
Narrative Update: Leidos Holdings Analysts have trimmed their blended price target on Leidos Holdings by about $1 per share to $219, reflecting slightly more conservative assumptions on revenue growth, margins, and future P/E, after balancing recent target increases from firms citing strong execution and portfolio positioning with concerns around a key high margin contract and the timing of proving its sustainability. Analyst Commentary Recent research on Leidos highlights a mix of optimism around the core business and caution around a key contract that could affect medium term growth and valuation multiples.Actualización de narrativa • Jan 07
LDOS: Health And Civil Strength And Pipeline Visibility Will Support Premium Multiple
Analysts have nudged their fair value estimate for Leidos Holdings higher to about $219.85 from roughly $218.08, citing stronger recent earnings, solid Health & Civil margins, a 1.3x book to bill, a US$69b near term pipeline, and a view that the company merits a premium P/E multiple within government services. Analyst Commentary Bullish Takeaways Bullish analysts see the recent earnings beat as support for a higher fair value, pointing to execution in Health & Civil margins as a key driver of profitability.Actualización de narrativa • Dec 16
LDOS: Strong Health And Civil Margins Will Support Future Premium Multiple
Analysts have raised their price target on Leidos Holdings to approximately $218.08 per share from about $218.08. This reflects slightly stronger expectations for revenue growth and sustained margins, supported by robust book to bill trends, a sizable near term pipeline, and upside earnings performance with higher profitability guidance into 2025.Actualización de narrativa • Dec 02
LDOS: Strong Health And Civil Margins Will Support Continued Margin Upside
Leidos Holdings saw its average analyst price target rise from $210 to $230 as analysts highlighted robust Health & Civil margins, a strong contract pipeline, and increased profitability guidance following recent earnings results. Analyst Commentary Recent analyst reports have highlighted several factors influencing sentiment around Leidos Holdings following the latest earnings results and guidance updates.Actualización de narrativa • Nov 18
LDOS: Near-Term Contract Pipeline Will Drive Continued Margin Upside
Leidos Holdings' analyst price target has increased from $201.83 to $218.08 per share, as analysts cite strong margins in Health and Civil segments, a robust $69 billion pipeline, and raised profitability guidance as driving factors for the upward revision. Analyst Commentary Recent analyst reports have highlighted several factors that shape both the bullish and cautious outlooks for Leidos Holdings following its stronger-than-expected earnings performance and revised guidance.Artículo de análisis • Nov 06
Leidos Holdings (NYSE:LDOS) Is Increasing Its Dividend To $0.43
Leidos Holdings, Inc. ( NYSE:LDOS ) will increase its dividend from last year's comparable payment on the 31st of...Actualización de narrativa • Nov 02
LDOS: Federal Health And Security Spending Will Drive Steady Performance Ahead
Leidos Holdings saw its analyst price target rise from approximately $198.50 to $201.83. Analysts cited the company’s ongoing momentum in health services, robust margins, and its positioning to benefit from expanding federal funding priorities.Actualización de narrativa • Oct 18
Government Funding And Digital Transformation Will Create Future Value
The average analyst price target for Leidos Holdings was raised by approximately $4 to $198.50. Analysts highlighted improving healthcare margins, stronger execution in health and defense services, and the company's positioning to benefit from recent government funding priorities.Actualización de narrativa • Oct 04
Government Funding And Digital Transformation Will Create Future Value
The analyst price target for Leidos Holdings has been increased by approximately $2 to $194.71, as analysts cite ongoing strength in healthcare margins, opportunities in defense solutions, and improved business execution as key factors supporting the higher valuation. Analyst Commentary Recent Street research updates reflect a generally positive outlook on Leidos Holdings, with multiple analysts raising their price targets and upgrading the stock in response to improved business execution and strong performance in key sectors.Actualización de narrativa • Sep 19
Government Funding And Digital Transformation Will Create Future Value
Upward analyst revisions for Leidos Holdings reflect confidence in its strategic investments in health and border security, strong healthcare margins, and effective leadership, resulting in a modest price target increase from $190.15 to $192.66. Analyst Commentary Bullish analysts highlight Leidos' strategic investments in veteran health, border security, and autonomous maritime, positioning the company to benefit from new government funding priorities.Artículo de análisis • Sep 06
Here's Why Leidos Holdings (NYSE:LDOS) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Actualización de narrativa • Sep 04
Government Funding And Digital Transformation Will Create Future Value
Analysts maintain a positive outlook on Leidos Holdings due to strong execution in Health Services, favorable positioning for government funding priorities, increased management confidence, and a strategic pivot toward higher-margin growth sectors, resulting in an unchanged $186.69 price target. Analyst Commentary Continued strength and solid execution within Leidos' Health Services business, contributing to improved outlook and confidence.Artículo de análisis • Jun 19
Does Leidos Holdings (NYSE:LDOS) Deserve A Spot On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Seeking Alpha • Apr 15
Leidos: A Defense Company To Consider
Summary Leidos Holdings, Inc. operates in defense, IT security, data analytics, and healthcare, recently realigning into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Leidos has shown strong performance, boasting a 450% total return over the past decade, exceeding returns of the overall market. The company has been growing its dividend for a few years, but I think they could offer investors higher increases. Read the full article on Seeking AlphaSeeking Alpha • Feb 02
Leidos: Fears Are Overblown, Take Advantage Of Market Uncertainty
Summary Leidos' shares have dropped significantly due to policy uncertainties, presenting a buying opportunity given its strong backlog and free cash flow generation. The company's Q3 '24 results showed robust growth with a 44% EPS increase and a $40.6 billion backlog, signaling future revenue stability. Despite political risks, Leidos' valuation is attractive at 10.3x EV/EBITDA, with strong dividend and share buyback potential. I rate Leidos a 'strong buy' due to its discounted valuation, solid financial position, and growth prospects in Health & Civil and National Security segments. Read the full article on Seeking AlphaSeeking Alpha • Nov 22
Leidos: Not Enough Margin Of Safety Despite Creating Value In A Low Growth Sector
Summary LDOS has consistently created shareholder value through a mix of organic growth and acquisitions. Despite improving operating and capital efficiencies, LDOS's returns have not shown an improving trend, and its valuation currently does not provide enough margin of safety. LDOS is financially sound with a good reinvestment rate and cash flow. But I recommend waiting for a 15% price drop before buying. Read the full article on Seeking AlphaPrevisiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2028 | 20,025 | 1,649 | 1,818 | 2,001 | 9 |
| 12/31/2027 | 19,119 | 1,547 | 1,662 | 1,871 | 15 |
| 12/31/2026 | 18,231 | 1,434 | 1,548 | 1,801 | 15 |
| 4/3/2026 | 17,329 | 1,413 | 1,859 | 1,993 | N/A |
| 1/2/2026 | 17,174 | 1,448 | 1,625 | 1,750 | N/A |
| 10/3/2025 | 17,332 | 1,405 | 1,338 | 1,506 | N/A |
| 7/4/2025 | 17,053 | 1,402 | 1,282 | 1,442 | N/A |
| 4/4/2025 | 16,932 | 1,333 | 1,226 | 1,380 | N/A |
| 1/3/2025 | 16,662 | 1,254 | 1,286 | 1,435 | N/A |
| 9/27/2024 | 16,277 | 1,199 | 1,304 | 1,445 | N/A |
| 6/28/2024 | 16,008 | 436 | 1,425 | 1,593 | N/A |
| 3/29/2024 | 15,714 | 321 | 1,191 | 1,376 | N/A |
| 12/29/2023 | 15,438 | 199 | 980 | 1,187 | N/A |
| 9/29/2023 | 15,155 | 147 | 804 | 986 | N/A |
| 6/30/2023 | 14,842 | 708 | 761 | 920 | N/A |
| 3/31/2023 | 14,601 | 672 | 661 | 801 | N/A |
| 12/30/2022 | 14,396 | 685 | 863 | 992 | N/A |
| 9/30/2022 | 14,190 | 682 | 968 | 1,077 | N/A |
| 7/1/2022 | 14,065 | 725 | 807 | 913 | N/A |
| 4/1/2022 | 13,916 | 723 | 779 | 885 | N/A |
| 12/31/2021 | 13,737 | 753 | 929 | 1,033 | N/A |
| 10/1/2021 | 13,498 | 776 | 635 | 769 | N/A |
| 7/2/2021 | 13,257 | 734 | 656 | 796 | N/A |
| 4/2/2021 | 12,723 | 718 | 1,036 | 1,201 | N/A |
| 1/1/2021 | 12,297 | 628 | 1,151 | 1,334 | N/A |
| 10/2/2020 | 11,999 | 612 | 1,381 | 1,555 | N/A |
| 7/3/2020 | 11,592 | 610 | 1,147 | 1,312 | N/A |
| 4/3/2020 | 11,406 | 593 | 941 | 1,076 | N/A |
| 1/3/2020 | 11,094 | 667 | N/A | 992 | N/A |
| 9/27/2019 | 10,787 | 674 | N/A | 927 | N/A |
| 6/28/2019 | 10,527 | 660 | N/A | 949 | N/A |
| 3/29/2019 | 10,328 | 668 | N/A | 1,034 | N/A |
| 12/28/2018 | 10,194 | 581 | N/A | 768 | N/A |
| 9/28/2018 | 10,063 | 507 | N/A | 828 | N/A |
| 6/29/2018 | 9,991 | 442 | N/A | 724 | N/A |
| 3/30/2018 | 10,033 | 396 | N/A | 619 | N/A |
| 12/29/2017 | 10,170 | 366 | N/A | 526 | N/A |
| 9/29/2017 | 10,229 | 311 | N/A | 483 | N/A |
| 6/30/2017 | 9,594 | 320 | N/A | 486 | N/A |
| 3/31/2017 | 8,311 | 263 | N/A | 392 | N/A |
| 12/30/2016 | 7,043 | 244 | N/A | 449 | N/A |
| 9/30/2016 | 5,803 | 341 | N/A | 365 | N/A |
| 7/1/2016 | 5,237 | 299 | N/A | 364 | N/A |
| 4/1/2016 | 5,206 | 295 | N/A | 443 | N/A |
| 1/1/2016 | 5,140 | 265 | N/A | 409 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (5.8% al año) de LDOS es superior a la tasa de ahorro (3.5%).
Beneficios vs. Mercado: Se prevé que los beneficios (5.8% al año) de LDOS crezcan menos que el mercado US (16.2% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de LDOS crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (5.2% al año) de LDOS crezcan más despacio que el mercado de US (11.2% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 5.2% al año) de LDOS crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de LDOS sea alta dentro de 3 años (26.3%)
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/05 23:37 |
| Precio de las acciones al final del día | 2026/06/05 00:00 |
| Beneficios | 2026/04/03 |
| Ingresos anuales | 2026/01/02 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Leidos Holdings, Inc. está cubierta por 24 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| John Eade | Argus Research Company |
| Peter Arment | Baird |
| David Strauss | Barclays |